StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > StageZero Life Sciences, Ltd Announces Corporate Update

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Apr 06, 2022 3:30pm

129 Views

Post# 34581739

RE:RE:RE:StageZero Life Sciences, Ltd Announces Corporate Update

so the excuse is that sometimes shareholders need to exist their positions for many reasons.

So these people didnt need to do this before but at an already pathetic level thats when they decide they need to?

if anyone actually thinks this NR will do anything then you are flipping nuts.

let the down turn continue tomorrow.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December